Member Info for BuenaVista

I believe the key question is not 'Profit vs Care?' but 'What are the business dangers - financial and reputational - of our competitors having access to this platform?'

You say that JT, but it could be Q4 in Alan's special calendar.

It does seem like it is taking an inordinate length of time to get open data processed and released. I can only hope they are intending to include C7 data. Maybe the FDA insisted on seeing the C7 data before approving fortnightly dosing AT A HIGHER LEVEL than previously expected, in which case, time lost now would be time saved by starting Phase 1a.2 at a higher dose. Maybe 256mg/m² (being ~2/3 of the C7 dose)? Even better would be 320mg/m² (256 + 25%). One can only dream.

I think I've found him on LinkedIn (a Sales Director), still active and with a no doubt busy life. People can disappear for no bad reason. I've not posted to my YouTube account for 6 years and haven't uploaded any videos for over 15 years. Other things can take priority.

Does he like and comment there?

Poirot's account on here is https://www.lse.co.uk/profiles/Poirot./ - still active but has only posted on a couple of occasions since mid May last year. Last post was July this year, which I missed. See his post of 22 Feb last year.

His account on Twitter - https://twitter.com/Poirot105 - has no posts since mid May last year.

I hope so. Would do wonders for the security of my pension.💰💰💰

You must have missed that bit nonsense fun Baffyman.

Sound bet. Reinvest your winnings into more Avacta shares. Or treat the family to tickets for the Donkey Derby panto at The Empire.

My guess though is that the SDMC will need to sign off C7 (that is, no MTD found and reaffirmation of intent to go to fortnightly dosing) and, that being market sensitive information, it will be RNS'ed.

Sadly, Poirot seems to have completely disappeared (never a good sign.)

Anyway, fear not children, it's coming up to panto season and puffft! appearing out a cloud of smokescreen it's Mystic Oph on his panto donkey, Spreadsheets, wielding his trusty sausage and spouting cryptic clues about the bestest sauces at MaccyD's and tales of production lines and Bots. Dontcha just luv Yule!

The price has been hiked.

It's a bit of a trek...

Completion of C7, approval of the protocol amendment to do fortnightly dosing (and to a higher dosing level?) from the FDA, and of course publication of the Phase 1a trial data (C1-C6) are all to be expected this quarter and can be expected over the next 10 non-Friday market days to 14th December.

All previous cohort completion announcements have been midweek, so it starts (or ends) tomorrow...

All this Oph reveals is a sausage. Thwack!

Oph

Are you saying that HurstBot has special inside knowledge or that you've only just twigged that there might be a licence deal in the near future?

There is a lot of "just getting with it" to be done. Think what's going on under the waterline as all the ducks line up.

Not this 'More trading' one. This one is special.

I like HurstBot's Thread Title module upgrade.

I've been asking myself how many Berenberg have been selling for.